المؤلفون: Krijn K. Dijkstra, José G. van den Berg, Fleur Weeber, Joris van de Haar, Arno Velds, Sovann Kaing, Dennis D. G. C. Peters, Ferry A. L. M. Eskens, Derk-Jan A. de Groot, Margot E. T. Tesselaar, Emile E. Voest

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Oncology

المصدر: Frontiers in endocrinology, 12:627819. Frontiers Media SA
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, 12:627819. Frontiers Media S.A.

مصطلحات موضوعية: 0301 basic medicine, Endocrinology, Diabetes and Metabolism, Gene Dosage, lcsh:Diseases of the endocrine glands. Clinical endocrinology, DNA Mismatch Repair, Models, Biological, gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC), 03 medical and health sciences, Endocrinology, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Stomach Neoplasms, Cell Line, Tumor, Intestinal Neoplasms, Exome Sequencing, disease modeling, medicine, Organoid, Humans, Neuroendocrine carcinoma, Everolimus, organoids, Original Research, Cisplatin, extrapulmonary neuroendocrine carcinoma, lcsh:RC648-665, Cell Death, biology, Chromogranin A, digestive system diseases, Pancreatic Neoplasms, Neuroendocrine Tumors, Ki-67 Antigen, 030104 developmental biology, Drug development, 030220 oncology & carcinogenesis, Mutation, Synaptophysin, biology.protein, Cancer research, Immunohistochemistry, medicine.drug, pre-clinical models

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b593f0c43d340ac146f31045b6cd17b1Test
https://hdl.handle.net/11370/fab0756b-5f30-4f43-aa6d-e1408866e72bTest

المؤلفون: Christiaan van der Leij, Krijn P. van Lienden, Jan J. J. de Vries, Nomdo S Renken, F. Daams, Ronald M. van Dam, C. Yung Nio, M. Liem, Thomas L. Bollen, Geert-Jan Creemers, Steffi J Rombouts, Judith de Vos-Geelen, Gijs A. Patijn, Maartje Los, Sebastiaan Festen, I. Quintus Molenaar, J. Nederend, Derk Jan A. de Groot, Rutger C G Bruijnen, Jan Willem B. de Groot, Joost G Blomjous, Leonie J. M. Mekenkamp, John J. Hermans, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Susana I S Patuleia, Johanna W. Wilmink, Thijs J Schouten, Maaike E Verweij, Lilly J H Brada, Hjalmar C. van Santvoort, Emile D. Kerver, Vincent E de Meijer, J.F.M. Pruijt, Annelie Vulink, Koop Bosscha, Frank J. Wessels, Maarten S. van Leeuwen, Marc G. Besselink, Marco B. Polee, Olivier R. Busch, Martijn R. Meijerink, M.S. Walma, Martijn W J Stommel

المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer biology and immunology, Ophthalmology, Internal medicine, VU University medical center, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: European Journal of Surgical Oncology, 47(3), 699-707. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137Test
European Journal of Surgical Oncology, 47, 699-707
European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 3, pp. 699-707

مصطلحات موضوعية: Male, Antimetabolites, Antineoplastic, medicine.medical_specialty, Paclitaxel, FOLFIRINOX, medicine.medical_treatment, Locally advanced pancreatic cancer, Leucovorin, Adenocarcinoma, Irinotecan, Deoxycytidine, Cohort Studies, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], All institutes and research themes of the Radboud University Medical Center, Pancreatectomy, Albumins, Internal medicine, Pancreatic cancer, treatment strategies, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, Prospective cohort study, Response Evaluation Criteria in Solid Tumors, Aged, Chemotherapy, business.industry, General Medicine, Middle Aged, medicine.disease, Gemcitabine, Neoadjuvant Therapy, Oxaliplatin, Pancreatic Neoplasms, Survival Rate, Oncology, Cohort, Treatment strategy, Female, Surgery, Fluorouracil, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8a66a9183508390e581990d356d615Test
https://doi.org/10.1016/j.ejso.2020.11.137Test

المؤلفون: R.M. van Dam, I. H. J. T. de Hingh, V. E. de Meijer, Leonie J. M. Mekenkamp, Johanna W. Wilmink, Derk Jan A. de Groot, Martijn R. Meijerink, N. Haj Mohammad, J.F.M. Pruijt, Koop Bosscha, Gijs A. Patijn, M. Los, Lilly J H Brada, H.C. van Santvoort, G.J.M. Creemers, Marco B. Polee, Sebastiaan Festen, Geert A. Cirkel, J. de Vos-Geelen, Emile D. Kerver, I.Q. Molenaar, M.G. Besselink, M. Liem, J. A. Ropela, M.S. Walma, J.W.B. de Groot, Martijn W J Stommel

المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
Pancreatology, 21, 163-169
Pancreatology, 21(1), 163-169. Elsevier
Pancreatology, 21, 1, pp. 163-169
Pancreatology, 21(1), 163-169. S. Karger AG
Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BV

مصطلحات موضوعية: Male, FOLFIRINOX, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Locally advanced pancreatic cancer, Kaplan-Meier Estimate, urologic and male genital diseases, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Elderly, DISPARITIES, Registries, NAB-PACLITAXEL, Aged, 80 and over, OUTCOMES, Incidence (epidemiology), Age Factors, Gastroenterology, Chemoradiotherapy, Induction Chemotherapy, Middle Aged, CHEMOTHERAPY, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, 030211 gastroenterology & hepatology, Best supportive care, medicine.drug, Adult, medicine.medical_specialty, Young Adult, 03 medical and health sciences, AGE, Drug Therapy, Internal medicine, Pancreatic cancer, Post-hoc analysis, medicine, Humans, Aged, Chemotherapy, Hepatology, OLDER PATIENTS, business.industry, ADENOCARCINOMA, medicine.disease, Survival Analysis, Comorbidity, Gemcitabine, Pancreatic Neoplasms, GEMCITABINE, business, COMORBIDITY

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5414ed7d7980dab4a07cdbd070c10f3dTest
https://research.vumc.nl/en/publications/01ec0bf4-0c27-4e80-99e6-7fc4c055e18fTest

المؤلفون: Mathieu D'Hondt, Sebastiaan Festen, Rutger C G Bruijnen, O.M. van Delden, E. M. van der Waal, I.H.J.T. de Hingh, J. A. Ropela, J. de Vos-Geelen, Johanna W. Wilmink, Chung Y. Nio, R.M. van Dam, Derk Jan A. de Groot, Geert Roeyen, J.W.B. de Groot, K.P. van Lienden, N. Haj Mohammad, S. J. Rombouts, O.R.C. Busch, Lilly J H Brada, G.J.M. Creemers, M. Liem, Gijs A. Patijn, J. de Vries, F. Daams, I.Q. Molenaar, V. E. de Meijer, M. S. van Leeuwen, Maartje Los, Leonie J. M. Mekenkamp, M.S. Walma, I. Oulad Abdennabi, P. Ghorbani, Martijn W J Stommel, H.C. van Santvoort, Elizabeth Pando, Emile D. Kerver, I. H. M. Borel Rinkes, J.F.M. Pruijt, R. van Hillegersberg, Koop Bosscha, Frank J. Wessels, Martijn R. Meijerink, Marc G. Besselink, Marco B. Polee

المساهمون: Dutch Pancreatic Cancer Group, Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, Internal medicine, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Institut Català de la Salut, [Walma MS, Rombouts SJ, Brada LJH] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Departments of Surgery, Radiology and Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Borel Rinkes IH, Bruijnen RC] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. [Bosscha K] Departments of Surgery and Medical Oncology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, CCA - Cancer Treatment and Quality of Life, Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, Laboratory for General Clinical Chemistry, Oncology

المصدر: Trials, 22, 1
Trials
Trials, 22
Trials, 22(1):313. BioMed Central
Dutch Pancreatic Cancer Group 2021, ' Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial ', Trials, vol. 22, no. 1, 313 . https://doi.org/10.1186/s13063-021-05248-yTest
Trials, 22(1):313. BioMed Central Ltd
TRIALS, 22(1):313, 1-12. BMC
Scientia
Trials, Vol 22, Iss 1, Pp 1-12 (2021)

مصطلحات موضوعية: Oncology, Medicine (General), Radiofrequency ablation, FOLFIRINOX, SURGERY, medicine.medical_treatment, Locally advanced pancreatic cancer, INTERNATIONAL STUDY-GROUP, Medicine (miscellaneous), 030230 surgery, law.invention, Study Protocol, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Quimioteràpia, Clinical endpoint, Multicenter Studies as Topic, Pharmacology (medical), Overall survival, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Otros calificadores::/terapia [Otros calificadores], Netherlands, Randomized Controlled Trials as Topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Extirpació (Cirurgia), TUMORS, Progression-Free Survival, 030220 oncology & carcinogenesis, SURVIVAL, terapéutica::tratamiento de radiofrecuencia::ablación por radiofrecuencia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, Therapeutics::Radiofrequency Therapy::Radiofrequency Ablation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], 03 medical and health sciences, R5-920, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Pancreatic cancer, Pàncrees - Càncer - Tractament, medicine, Humans, Chemotherapy, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Cancer, ADENOCARCINOMA, Other subheadings::/therapy [Other subheadings], medicine.disease, PHASE-III, Gemcitabine, Pancreatic Neoplasms, DEFINITION, GEMCITABINE, Human medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3471da294f3f1dbd689adeaf8e6be22Test
https://repository.ubn.ru.nl/handle/2066/239066Test

المؤلفون: B.M. Zonderhuis, Tom C.J. Seerden, N. C. M. van Huijgevoort, E. J. M. van Geenen, Leonie J. M. Mekenkamp, Koop Bosscha, C. Wientjes, R. C. Verdonk, Gijs A. Patijn, Rutger Quispel, L.G.M. van der Geest, Lodewijk A.A. Brosens, Frank J. Wessels, M. G. H. van Oijen, O.R.C. Busch, A. Bogte, Johanna W. Wilmink, Emile D. Kerver, Lieke Hol, Tara M. Mackay, J. Verheij, H. Lubbinge, Marjolein Y.V. Homs, I. Q. Molenaar, A.J. ten Tije, B. C. M. Haberkorn, Jennifer M.J. Schreinemakers, V E de Meijer, C.H. van Werkhoven, H.C. van Santvoort, Saskia A C Luelmo, Wouter L. Curvers, C.H.J. van Eijck, F.J. Smits, J. E. van Hooft, F. G. I. van Vilsteren, L. M. J. W. van Driel, F. Wit, Derk Jan A. de Groot, J. T. Haver, Bert A. Bonsing, H. Schut, I.H.J.T. de Hingh, J.W.B. de Groot, N. Haj Mohammad, H.W.M. van Laarhoven, H. Bos, Niels G. Venneman, M. den Dulk, L.B. van Rijssen, Martijn W J Stommel, Sebastiaan Festen, Tessa E H Römkens, Chantal V Hoge, Annelie Vulink, J. de Vos-Geelen, Gjm Hemmink, Marc Jacobs, G.J.M. Creemers, Anouk E J Latenstein, S. van Dieren, Marc G. Besselink, Mike Liem, E. van der Harst, Maartje Los

المساهمون: Surgery, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, APH - Methodology, Oncology, APH - Quality of Care, Ear, Nose and Throat, Graduate School, Pathology, Gastroenterology and Hepatology, CCA -Cancer Center Amsterdam, Gastroenterology and hepatology, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Gastroenterology & Hepatology, Medical Oncology, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9)

المصدر: MacKay, T M, Smits, F J, Latenstein, A E J, Bogte, A, Bonsing, B A, Bos, H, Bosscha, K, Brosens, L A A, Hol, L, Busch, O R C, Creemers, G J, Curvers, W L, Den Dulk, M, Van Dieren, S, Van Driel, L M J W, Festen, S, Van Geenen, E J M, Van Der Geest, L G, De Groot, D J A, De Groot, J W B, Haj Mohammad, N, Haberkorn, B C M, Haver, J T, Van Der Harst, E, Hemmink, G J M, De Hingh, I H, Hoge, C, Homs, M Y V, Van Huijgevoort, N C, Jacobs, M A J M, Kerver, E D, Liem, M S L, Los, M, Lubbinge, H, Luelmo, S A C, De Meijer, V E, Mekenkamp, L, Molenaar, I Q, Van Oijen, M G H, Patijn, G A, Quispel, R, Van Rijssen, L B, Römkens, T E H, Van Santvoort, H C, Schreinemakers, J M J, Schut, H, Seerden, T, Stommel, M W J, Ten Tije, A J, Venneman, N G, Verdonk, R C, Verheij, J, Van Vilsteren, F G I, De Vos-Geelen, J, Vulink, A, Wientjes, C, Wit, F, Wessels, F J, Zonderhuis, B, Van Werkhoven, C H, Van Hooft, J E, Van Eijck, C H J, Wilmink, J W, Van Laarhoven, H W M & Besselink, M G 2020, ' Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1) : A multicenter stepped-wedge cluster randomized controlled trial ', Trials, vol. 21, no. 1, 334 . https://doi.org/10.1186/s13063-020-4180-zTest
Trials, 21
Trials
Trials, 21(1):334. BioMed Central
TRIALS, 21(1):334. BMC
Trials, 21(1). BMC
Trials, 21(1). BioMed Central Ltd.
Trials, 21, 1
Trials, Vol 21, Iss 1, Pp 1-18 (2020)
Trials, 21(1). BioMed Central
Trials, 21(1):334. BioMed Central Ltd

مصطلحات موضوعية: Male, Survival, Medicine (miscellaneous), GUIDELINES, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Study Protocol, 0302 clinical medicine, Superiority Trial, Randomized controlled trial, DESIGN, law, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Cluster Analysis, Multicenter Studies as Topic, Pharmacology (medical), 030212 general & internal medicine, Child, Netherlands, Randomized Controlled Trials as Topic, Aged, 80 and over, lcsh:R5-920, Pancreatic enzyme replacement therapy, STATEMENT, Palliative Care, Middle Aged, Neoadjuvant Therapy, Biliary Tract Surgical Procedures, Treatment Outcome, 030220 oncology & carcinogenesis, Child, Preschool, Drainage, Female, Stents, lcsh:Medicine (General), Carcinoma, Pancreatic Ductal, Adult, Quality of life, medicine.medical_specialty, Best practices, Registry, RESECTION, Referral, Adolescent, Best practice, Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0], Biliary drainage, Disease cluster, Pancreaticoduodenectomy, 03 medical and health sciences, Young Adult, Quality of life (healthcare), SDG 3 - Good Health and Well-being, Pancreatic cancer, medicine, Journal Article, Humans, Chemotherapy, Enzyme Replacement Therapy, Stepped-wedge cluster randomized controlled trial, Aged, business.industry, Health Plan Implementation, Infant, Newborn, Infant, Guideline, medicine.disease, Pancreatic Neoplasms, SAMPLE-SIZE, Implementation, Emergency medicine, Patient Compliance, business

وصف الملف: application/pdf; text/plain

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc579abe0c6c89b5b53855fba26161ceTest
https://research.vumc.nl/en/publications/9cf33a71-45a4-4cac-b43f-782103a25fe1Test

المؤلفون: Gooitzen M. van Dam, Rudolf S N Fehrmann, Xiao Juan Zhao, Derk Jan A. de Groot, Marjory Koller, Wouter B. Nagengast, Elmire Hartmans

المصدر: Journal of Nuclear Medicine. 58:1899-1903

مصطلحات موضوعية: 0301 basic medicine, pancreatic cancer, targeted molecular imaging, ADENOCARCINOMAS, Theranostic Nanomedicine, Drug Delivery Systems, Pancreatic tumor, Targeted Molecular Therapy, Pathology, Molecular, PROBE, biology, gamma-Glutamyltransferase, Up-Regulation, Gene Expression Regulation, Neoplastic, Mesothelin, biomarker, Carcinoma, Pancreatic Ductal, medicine.drug, Prioritization, pancreatic ductal adenocarcinoma (PDA), Nanotechnology, GPI-Linked Proteins, OVARIAN-CANCER, 03 medical and health sciences, Downregulation and upregulation, Pancreatic cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, RNA, Messenger, theranostic approach, IDENTIFICATION, business.industry, Mucin-1, medicine.disease, Cathepsins, Gemcitabine, CATHEPSIN-E, Pancreatic Neoplasms, MICE, 030104 developmental biology, GEMCITABINE, ANTIBODY, targeted molecular therapy, Cancer research, biology.protein, genetic profiling, business, Ovarian cancer, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b3286a21a676d392a524c28c54925bTest
https://doi.org/10.2967/jnumed.117.198440Test